PLTTECH Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 4

PLTTECH General Information

Description

Research and developer of single-cell precision research solutions. The company focuses in the research of precision medicine and applies technology research and innovation results to disease research and health management. The company utilizes technologies such as single cell detection, protein dynamic detection and biological big data analysis to provide solutions for precision medicine.

Contact Information

Website
www.plttech.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 3rd Floor, Building 5, Zhejiang China Europe International Medical Research Center
  • No. 2622, Yuhangtang Road, Yuhang District
  • Hangzhou, Zhejiang
  • China
+86 0571
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Biotechnology
Vertical(s)
Big Data, Life Sciences
Corporate Office
  • 3rd Floor, Building 5, Zhejiang China Europe International Medical Research Center
  • No. 2622, Yuhangtang Road, Yuhang District
  • Hangzhou, Zhejiang
  • China
+86 0571

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

PLTTECH Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC 06-Aug-2022 Completed Generating Revenue
2. Early Stage VC 31-Jul-2020 Completed Pre-Clinical Trials
1. Early Stage VC 06-Dec-2017 $1.51M $1.51M Completed Startup
To view PLTTECH’s complete valuation and funding history, request access »

PLTTECH Patents

  • 7

    Total Documents Applications and Grants

  • Total Patents Families

  • 5

    Granted

  • 1

    Pending

  • Expiring in next 12 mo

PLTTECH Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2023197182-A1 Antibody combination for replacing side scatter signal in mass cytometry hematological tumor immunophenotyping, and uses Inactive 11-Apr-2022
EP-4261220-A1 Antibody combination for substituting side scatter signal in mass cytometry hematologic tumor immunophenotyping and use thereof Active 11-Apr-2022
EP-4261220-B1 Antibody combination for substituting side scatter signal in mass cytometry hematologic tumor immunophenotyping and use thereof Active 11-Apr-2022
EP-4261220-C0 Antibody combination for substituting side scatter signal in mass cytometry hematologic tumor immunophenotyping and use thereof Active 11-Apr-2022
US-20230324395-A1 Antibody combination for substituting side scatter signal in mass cytometry hematologic tumor immunophenotyping and use thereof Pending 11-Apr-2022 G01N33/5758
To view PLTTECH’s complete patent history, request access »

PLTTECH Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Hexin Instrument Corporation Minority
Nantong Blue Bay Venture Capital Management Growth/Expansion Minority
Zheshang Venture Capital Venture Capital Minority
ZJKF Capital Management Venture Capital Minority
To view PLTTECH’s complete investors history, request access »

Ready to get started?

Request a free trial

PLTTECH FAQs

  • When was PLTTECH founded?

    PLTTECH was founded in 2015.

  • Where is PLTTECH headquartered?

    PLTTECH is headquartered in Hangzhou, China.

  • What industry is PLTTECH in?

    PLTTECH’s primary industry is Discovery Tools (Healthcare).

  • Is PLTTECH a private or public company?

    PLTTECH is a Private company.

  • What is PLTTECH’s current revenue?

    The current revenue for PLTTECH is .

  • How much funding has PLTTECH raised over time?

    PLTTECH has raised $2.94M.

  • Who are PLTTECH’s investors?

    Hexin Instrument, Nantong Blue Bay Venture Capital Management, Zheshang Venture Capital, and ZJKF Capital Management have invested in PLTTECH.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process